Submitted on February 7, 2017 - USP Comment Letter to FDA on the FDA's issuance of the List of Bulk Drug Substances that Can Be Used To Compound Drug Products in Accordance With Section 503A of the Federal Food, Drug, and Cosmetic Act. Docket Number FDA-2016-N-3464.
